Eli Lilly and Company

Eli Lilly and Company, which has been in business for more than 132 years, is a global, research-based company at the forefront of many significant medical breakthroughs, including the purification of insulin for the treatment of diabetes, developing a method to mass-produce penicillin, and launching erythromycin, an antibiotic whose broad antimicrobial spectrum expands the alternatives for penicillin-allergic patients. See http://www.lilly.com.